bucindolol has been researched along with phenylephrine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marwood, JF; Stokes, GS | 1 |
| Curzio, J; Reid, JL; Vincent, J | 1 |
| Cushing, DJ; Fink, GD; Silver, PJ; Watts, SW | 1 |
3 other study(ies) available for bucindolol and phenylephrine
| Article | Year |
|---|---|
Bucindolol has serotonin and alpha-adrenoceptor blocking properties.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; In Vitro Techniques; Ketanserin; Male; Phenylephrine; Piperidines; Prazosin; Propanolamines; Rats; Rats, Inbred Strains; Regional Blood Flow; Serotonin Antagonists | 1985 |
Bucindolol in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Creatine Kinase; Drug Administration Schedule; Heart Rate; Humans; Hypertension; Isoproterenol; Middle Aged; Norepinephrine; Phenylephrine; Posture; Propanolamines; Receptors, Adrenergic, alpha; Renin | 1985 |
Interaction of the beta adrenergic receptor antagonist bucindolol with serotonergic receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Coronary Vessels; Gastric Fundus; Hemodynamics; In Vitro Techniques; Male; Phenylephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Stereoisomerism; Swine | 2000 |